4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,000.00p
   
  • Change Today:
      30.00p
  • 52 Week High: 1,500.00p
  • 52 Week Low: 930.00p
  • Currency: UK Pounds
  • Shares Issued: 15.54m
  • Volume: 7
  • Market Cap: £155.39m

Deal with Barclays    Trade now with Barclays Stockbrokers

Latest Deals

Traded Action Notifier PriceAmountValue
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00

Largest Deals (365 days)

Traded Action Notifier PriceAmountValue
15-Nov-24 Sell Heikki Lanckriet 1,325.00p 46,500 £616,125.00
15-Nov-24 Buy Heikki Lanckriet 1,325.00p 46,500 £616,125.00
02-Apr-25 Buy Heikki Lanckriet 1,205.00p 2,400 £28,920.00
28-Feb-25 Buy Amy Walker 1,120.00p 1,151 £12,891.20

Director Shareholdings

Notifier Holding Value*
Heikki Lanckriet 1,117,688 £11,176,880
Amy Walker 44,016 £440,160
Maria Del Pilar de la Huerta 6,667 £66,670
Hansjörg Plaggemars 6,667 £66,670

Major Shareholders

Notifier** Holding Value*
Wilhelm K. T. Zours 5,119,743 £51,197,430
DELPHI Unternehmensberatung AG 5,119,743 £51,197,430
4bb AG 5,115,852 £51,158,520
M&G Plc 4,627,741 £46,277,410
Elevage Medical Technologies Holdings 4,627,741 £46,277,410
Deutsche Balaton AG 4,432,637 £44,326,370
2invest AG 2,229,083 £22,290,830
Sparta AG 1,351,718 £13,517,180
Latonba AG 778,891 £7,788,910
Franciscus De Busschere 537,255 £5,372,550

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

4basebio Market Data

Currency UK Pounds
Share Price 1,000.00p
Change Today 30.00p
% Change 3.09 %
52 Week High 1,500.00p
52 Week Low 930.00p
Volume 7
Shares Issued 15.54m
Market Cap £155.39m

4basebio Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
65.92% below the market average65.92% below the market average65.92% below the market average65.92% below the market average65.92% below the market average
6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average6.98% above the sector average
Price Trend
23.4% below the market average23.4% below the market average23.4% below the market average23.4% below the market average23.4% below the market average
6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average6.67% above the sector average
Income Not Available
Growth
59.18% above the market average59.18% above the market average59.18% above the market average59.18% above the market average59.18% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

4basebio Dividends

No dividends found

Trades for 05-Aug-2025

Time Volume / Share Price
16:35 1 @ 1,000.00p
16:35 1 @ 1,000.00p
14:00 1 @ 943.00p
14:00 1 @ 930.00p
14:00 1 @ 930.00p

4basebio Key Personnel

CEO Heikki Lanckriet
CFO David John Roth

Top of Page